Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 130

1.

Adult living donor versus deceased donor liver transplantation: a 10-year prospective single center experience.

Fisher RA, Cotterell AH, Maluf DG, Stravitz RT, Ashworth A, Nakatsuka M, Sterling RK, Luketic VA, Behnke MK, Posner MP.

Ann Hepatol. 2009 Oct-Dec;8(4):298-307.

PMID:
20009128
2.

Adult living donor versus deceased donor liver transplantation: a 6-year single center experience.

Maluf DG, Stravitz RT, Cotterell AH, Posner MP, Nakatsuka M, Sterling RK, Luketic VA, Shiffman ML, Ham JM, Marcos A, Behnke MK, Fisher RA.

Am J Transplant. 2005 Jan;5(1):149-56.

3.

Comparative analysis of hepatitis C recurrence and fibrosis progression between deceased-donor and living-donor liver transplantation: 8-year longitudinal follow-up.

Jain A, Singhal A, Kashyap R, Safadjou S, Ryan CK, Orloff MS.

Transplantation. 2011 Aug 27;92(4):453-60. doi: 10.1097/TP.0b013e3182259282.

PMID:
21799468
4.

Survival and hepatitis C virus recurrence after liver transplantation in HIV- and hepatitis C virus-coinfected patients: experience in a single center.

Testillano M, Fernandez JR, Suarez MJ, Gastaca M, Bustamante J, Pijoan JI, Montejo M, Valdivieso A, Ruiz P, Gonzalez J, Ortiz de Urbina J.

Transplant Proc. 2009 Apr;41(3):1041-3. doi: 10.1016/j.transproceed.2009.02.030.

PMID:
19376421
5.

The impact of donor variables on the outcome of orthotopic liver transplantation for hepatitis C.

Yagci G, Fernandez LA, Knechtle SJ, D'Alessandro AM, Chin LT, Musat AI, Lucey MR, Said A, Pirsch JD, Leverson G, Kalayoglu M.

Transplant Proc. 2008 Jan-Feb;40(1):219-23. doi: 10.1016/j.transproceed.2007.11.058.

PMID:
18261591
6.
7.

Domino versus deceased donor liver transplantation: association with early graft function and perioperative bleeding.

Bispo M, Marcelino P, Marques HP, Martins A, Perdigoto R, Aguiar MJ, MourĂ£o L, Barroso E.

Liver Transpl. 2011 Mar;17(3):270-8. doi: 10.1002/lt.22210.

8.

Model for End-Stage Liver Disease score does not predict patient or graft survival in living donor liver transplant recipients.

Hayashi PH, Forman L, Steinberg T, Bak T, Wachs M, Kugelmas M, Everson GT, Kam I, Trotter JF.

Liver Transpl. 2003 Jul;9(7):737-40.

9.

Outcome of living donor liver transplantation for Egyptian patients with hepatitis C (genotype 4)-related cirrhosis.

Yosry A, Esmat G, El-Serafy M, Omar A, Doss W, Said M, Abdel-Bary A, Hosny A, Marawan I, El-Malt O, Kamel RR, Hatata Y, Ghali A, Sabri H, Kamel S, El-Gbaly H, Tanaka K.

Transplant Proc. 2008 Jun;40(5):1481-4. doi: 10.1016/j.transproceed.2008.03.085.

PMID:
18589133
10.

Living donor liver transplantation for hepatitis C-related cirrhosis: no difference in histological recurrence when compared to deceased donor liver transplantation recipients.

Guo L, Orrego M, Rodriguez-Luna H, Balan V, Byrne T, Chopra K, Douglas DD, Harrison E, Moss A, Reddy KS, Williams JW, Rakela J, Mulligan D, Vargas HE.

Liver Transpl. 2006 Apr;12(4):560-5.

11.

Comparison of hepatitis C histological recurrence rates and patient survival between split and deceased donor liver transplantation.

Lawal A, Ghobrial R, Te H, Artinian L, Eastwood D, Schiano TD.

Transplant Proc. 2007 Dec;39(10):3261-5.

PMID:
18089367
12.

A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.

Selzner M, Kashfi A, Cattral MS, Selzner N, Greig PD, Lilly L, McGilvray ID, Therapondos G, Adcock LE, Ghanekar A, Levy GA, Renner EL, Grant DR.

Liver Transpl. 2009 Dec;15(12):1776-82. doi: 10.1002/lt.21955.

13.

Liver retransplantation of patients with hepatitis C infection is associated with acceptable patient and graft survival.

Ghabril M, Dickson RC, Machicao VI, Aranda-Michel J, Keaveny A, Rosser B, Bonatti H, Krishna M, Yataco M, Satyanarayana R, Harnois D, Hewitt W, Willingham DD, Grewal H, Hughes CB, Nguyen J.

Liver Transpl. 2007 Dec;13(12):1717-27.

14.

Risk factors in liver retransplantation: a single-center experience.

Crivellin C, De Martin E, Germani G, Gambato M, Senzolo M, Russo FP, Vitale A, Zanus G, Cillo U, Burra P.

Transplant Proc. 2011 May;43(4):1110-3. doi: 10.1016/j.transproceed.2011.01.141.

PMID:
21620065
16.

HLA tissue typing has no effect on the outcome of patients undergoing a living-donor liver transplant: a single-center experience in Egypt.

Yosry A, Said M, Esmat G, Al-Serafy M, Omar A, Doss W, Omran D, Saad Y, Kamel S, Abdel-Bary A, Hatata Y, Hosny A.

Exp Clin Transplant. 2012 Apr;10(2):136-40.

17.

Impact of donor histology on survival following liver transplantation for chronic hepatitis C virus infection: a Scandinavian single-center experience.

Ydreborg M, Westin J, Lagging M, Castedal M, Friman S.

Scand J Gastroenterol. 2012 Jun;47(6):710-7. doi: 10.3109/00365521.2012.672592. Epub 2012 Mar 27.

PMID:
22452366
18.

Impact of donor age and year of transplantation on graft and patient survival following liver transplantation for hepatitis C virus.

Mutimer DJ, Gunson B, Chen J, Berenguer J, Neuhaus P, Castaing D, Garcia-Valdecasas JC, Salizzoni M, Moreno GE, Mirza D.

Transplantation. 2006 Jan 15;81(1):7-14.

PMID:
16421468
19.

Whole liver versus split liver versus living donor in the adult recipient: an analysis of outcomes by graft type.

Humar A, Beissel J, Crotteau S, Kandaswamy R, Lake J, Payne W.

Transplantation. 2008 May 27;85(10):1420-4. doi: 10.1097/TP.0b013e31816de1a3.

PMID:
18497681
20.

Live donor liver transplantation in high MELD score recipients.

Selzner M, Kashfi A, Cattral MS, Selzner N, McGilvray ID, Greig PD, Levy GA, Renner EL, Grant DR.

Ann Surg. 2010 Jan;251(1):153-7. doi: 10.1097/SLA.0b013e3181bc9c6a.

PMID:
19858705

Supplemental Content

Support Center